NasdaqGS - Delayed Quote
USD
Kiniksa Pharmaceuticals International, plc (KNSA)
77.91
-2.56
(-3.18%)
At close: September 4 at 4:00:01 PM EDT
78.75
+0.84
(+1.08%)
After hours: September 4 at 7:59:19 PM EDT
Trade KNSA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for KNSA
- Previous Close
80.47 - Open
79.77 - Bid 56.88 x 200
- Ask 101.76 x 200
- Day's Range
77.90 - 80.43 - 52 Week Range
35.20 - 82.94 - Volume
429,616 - Avg. Volume
733,680 - Market Cap (intraday)
5.994B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
78.70 - EPS (TTM)
0.99 - Earnings Date Oct 27, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
98.00
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
KNSA
88.87%
S&P 500 (^GSPC)
12.75%
1-Year Return
KNSA
119.40%
S&P 500 (^GSPC)
18.71%
3-Year Return
KNSA
338.68%
S&P 500 (^GSPC)
70.93%
5-Year Return
KNSA
532.39%
S&P 500 (^GSPC)
70.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/3/2026
-
Market Cap
6.28B
-
Enterprise Value
5.76B
-
Trailing P/E
81.27
-
Forward P/E
62.89
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
7.84
-
Price/Book (mrq)
9.60
-
Enterprise Value/Revenue
6.85
-
Enterprise Value/EBITDA
56.46
Financial Highlights
Profitability and Income Statement
-
Profit Margin
9.59%
-
Return on Assets (ttm)
8.05%
-
Return on Equity (ttm)
14.04%
-
Revenue (ttm)
840.85M
-
Net Income Avi to Common (ttm)
80.66M
-
Diluted EPS (ttm)
0.99
Balance Sheet and Cash Flow
-
Total Cash (mrq)
525.93M
-
Total Debt/Equity (mrq)
1.36%
-
Levered Free Cash Flow (ttm)
126.14M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
77.91
-3.18%
Mkt Cap
5.994B
Industry
Drug Manufacturers—Specialty & Generic
23.18
-2.77%
Mkt Cap
986.03M
Industry
Drug Manufacturers—Specialty & Generic
34.94
+0.32%
Mkt Cap
4.124B
Industry
Drug Manufacturers—Specialty & Generic
34.10
+0.41%
Mkt Cap
3.8B
Industry
Drug Manufacturers—Specialty & Generic
2.2000
+1.85%
Mkt Cap
257.01M
Industry
Drug Manufacturers—Specialty & Generic
487.61
-0.54%
Mkt Cap
20.914B
Industry
Drug Manufacturers—Specialty & Generic
17.44
-2.41%
Mkt Cap
6.074B
Industry
Drug Manufacturers—Specialty & Generic
4.2600
-0.70%
Mkt Cap
703.922M
Industry
Drug Manufacturers—Specialty & Generic
71.23
-1.06%
Mkt Cap
1.636B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
